Developing Violence Prevention Therapy for Substance Abusers

NCT ID: NCT00551863

Last Updated: 2015-08-07

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE1/PHASE2

Total Enrollment

131 participants

Study Classification

INTERVENTIONAL

Study Start Date

2004-06-30

Study Completion Date

2008-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this project is to develop and pilot test a violence prevention intervention for men and women in treatment for substance use problems.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Substance Use Disorders Violence

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

IVPT

Intervention based on Motivational Interviewing and CBT

Group Type ACTIVE_COMPARATOR

IVPT

Intervention Type BEHAVIORAL

Violence prevention intervention based on Motivational Interviewing and CBT

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

IVPT

Violence prevention intervention based on Motivational Interviewing and CBT

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Presence of substance use related problems
* Interpersonal Violence history in the year before recruitment

Exclusion Criteria

* Primary opiate dependence
* Presence of active psychotic disorder
* \< 18 years of age
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Institute on Drug Abuse (NIDA)

NIH

Sponsor Role collaborator

University of Michigan

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Stephen Chermack

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Stephen T Chermack, Ph.D.

Role: PRINCIPAL_INVESTIGATOR

University of Michigan

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Michigan

Ann Arbor, Michigan, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Epstein-Ngo QM, Walton MA, Sanborn M, Kraus S, Blow F, Cunningham R, Chermack ST. Distal and proximal factors associated with aggression towards partners and non-partners among patients in substance abuse treatment. J Subst Abuse Treat. 2014 Oct;47(4):282-92. doi: 10.1016/j.jsat.2014.05.005. Epub 2014 Jun 10.

Reference Type BACKGROUND
PMID: 25012548 (View on PubMed)

Ilgen MA, Chermack ST, Murray R, Walton MA, Barry KL, Wojnar M, Blow FC. The association between partner and non-partner aggression and suicidal ideation in patients seeking substance use disorder treatment. Addict Behav. 2009 Feb;34(2):180-6. doi: 10.1016/j.addbeh.2008.10.004. Epub 2008 Oct 10.

Reference Type BACKGROUND
PMID: 18977093 (View on PubMed)

Chermack ST, Murray RL, Winters JJ, Walton MA, Booth BM, Blow FC. Treatment needs of men and women with violence problems in substance use disorder treatment. Subst Use Misuse. 2009;44(9-10):1236-62. doi: 10.1080/10826080902960007.

Reference Type BACKGROUND
PMID: 19938916 (View on PubMed)

Murray RL, Chermack ST, Walton MA, Winters J, Booth BM, Blow FC. Psychological aggression, physical aggression, and injury in nonpartner relationships among men and women in treatment for substance-use disorders. J Stud Alcohol Drugs. 2008 Nov;69(6):896-905. doi: 10.15288/jsad.2008.69.896.

Reference Type BACKGROUND
PMID: 18925348 (View on PubMed)

Chermack ST, Murray RL, Walton MA, Booth BA, Wryobeck J, Blow FC. Partner aggression among men and women in substance use disorder treatment: correlates of psychological and physical aggression and injury. Drug Alcohol Depend. 2008 Nov 1;98(1-2):35-44. doi: 10.1016/j.drugalcdep.2008.04.010. Epub 2008 Jun 13.

Reference Type BACKGROUND
PMID: 18554825 (View on PubMed)

Chermack ST, Grogan-Kaylor A, Perron BE, Murray RL, De Chavez P, Walton MA. Violence among men and women in substance use disorder treatment: a multi-level event-based analysis. Drug Alcohol Depend. 2010 Dec 1;112(3):194-200. doi: 10.1016/j.drugalcdep.2010.06.005. Epub 2010 Jul 27.

Reference Type BACKGROUND
PMID: 20667666 (View on PubMed)

Chermack ST, Bonar EE, Ilgen MA, Walton MA, Cunningham RM, Booth BM, Blow FC. Developing an Integrated Violence Prevention for Men and Women in Treatment for Substance Use Disorders. J Interpers Violence. 2017 Feb;32(4):581-603. doi: 10.1177/0886260515586369. Epub 2016 Jul 11.

Reference Type RESULT
PMID: 26002873 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

R01DA017295

Identifier Type: NIH

Identifier Source: secondary_id

View Link

R01DA017295-01A1

Identifier Type: NIH

Identifier Source: org_study_id

View Link

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.